TrialBritish journal of clinical pharmacology2003

Add-on therapy with montelukast or formoterol in patients with the glycine-16 beta2-receptor genotype.

Erika J Sims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.